Related Experiment Video

Updated: Apr 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

High-Sensitivity C-Reactive Protein and Statin Initiation

Andreja Trpkovic1, Julijana Stanimirovic1, Manfredi Rizzo2

  • 1Laboratory of Radiobiology and Molecular Genetics and Laboratory for Molecular Biology and Endocrinology, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia.

Angiology
|July 24, 2014
PubMed

Insights

High-sensitivity C-reactive protein (hsCRP) may help predict cardiovascular risk in patients lacking traditional risk factors. This review explores hsCRP

Area of Science:

  • Cardiology
  • Inflammation Biology
  • Biomarker Research

Background:

  • Cardiovascular diseases (CVD) pose a significant global health burden.
  • Inflammation is increasingly understood as a critical factor in atherosclerosis development.
  • Many individuals experiencing cardiovascular events do not exhibit conventional risk factors.

Purpose of the Study:

  • To review the role of high-sensitivity C-reactive protein (hsCRP) in cardiovascular risk assessment.
  • To evaluate the impact of hsCRP levels on the decision to initiate statin therapy.

Main Methods:

  • Literature review focusing on hsCRP as a biomarker.
  • Analysis of studies examining the association between hsCRP and cardiovascular events.
  • Examination of clinical guidelines and research on statin therapy initiation based on hsCRP.

Main Results:

  • hsCRP is a valuable marker of inflammation and can improve cardiovascular risk prediction.
  • Elevated hsCRP levels may indicate increased risk, even in the absence of traditional risk factors.
  • hsCRP can inform clinical decisions regarding the initiation of preventive therapies like statins.

Conclusions:

  • hsCRP provides incremental prognostic information beyond traditional risk factors for cardiovascular disease.
  • Measurement of hsCRP may aid in identifying individuals who would benefit from statin therapy.
  • Integrating hsCRP into risk assessment strategies can enhance primary and secondary prevention efforts for CVD.

Keywords:
C-reactive proteinbiomarkercardiovascular diseasehigh-sensitivity C-reactive proteininflammationstatins

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
719
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
958